Scroll Up Top
Download icon
Download

At a time of heightened unpredictability in an evolving world order, where can investors find some element of consistency? We believe that companies that have mastered the art of recurring revenues and pricing power are often underpinned by strong innovation. Innovation extends beyond disruptive or breakthrough inventions; we believe incremental innovation is a core strategy for maintaining relevance, driving competitive differentiation, and enabling long-term growth. In this first piece in a series about the culture of innovation, we examine how leading companies within one sector, consumer staples, drive continuous innovation to help strengthen their market positions and meet evolving client needs and expectations.

In order to thrive, even the world’s most enduring franchises have to keep evolving."

A sustained rhythm of innovation
In mature and well penetrated industries like consumer staples, achieving growth and maintaining pricing power requires a steady pipeline of innovations that address consumer needs, supported by sustained marketing investment and best-in-class execution. Consumer staples forms a smaller component of our quality portfolios these days and may be a sector less obviously associated with innovation than arenas such as information technology, but nonetheless we believe the select companies we choose to own within the sector remain world class operators with regards to innovation.

As an example, Procter & Gamble (P&G) allocates 14% of its revenue to research and development (R&D) and advertising,1 ensuring continuous product innovation. Over the past five decades, its U.S. fabric care business has maintained mid-single digit organic growth in a very mature category, fuelled by a robust innovation pipeline. This year, reinforcing their category leadership in detergents, the company introduced Tide EVO, a water-activated laundry tile incorporating fifty patents. Packaged as a dry tile rather than encased in plastic, the product should appeal to consumers who want to reduce plastic as well as energy use (activation in colder water means 90% less energy consumption), and its 100% concentration means no waste.

In our view, P&G’s growth strategy is a case study in disciplined execution. Its five pillars – product, packaging, brand communication, retail execution, and consumer and customer value – are not standalone tactics but interlocking components of a broader, integrated platform designed to drive market expansion. Innovation weaves through every element, from product design to shelf placement – a process designed for P&G to deliver products that resonate with consumers, outperform competitors and adapt swiftly to changing consumer needs. This combines to help sustain pricing power – leading to resilient gross margins – and keeps the product portfolio fresh and relevant in consumers’ minds and their regular purchasing habits.

Moving to the beauty industry, L’Oréal has embedded long-term R&D investment into its corporate culture, dedicating a significant 35% of revenue to R&D and marketing.2 This sustained commitment has enabled decades of mid-single digit organic growth. One example is the clinically tested Melasyl Serum, developed over 20 years, to address hyperpigmentation by targeting excess melanin accumulation. In our view, L’Oréal’s ability to translate scientific breakthroughs into commercially successful products underscores its leadership in the beauty industry. Quality companies use data and deep customer insights to innovate with precision – building loyalty and pricing power. L’Oréal has embraced digital and AI-powered personalisation tools, green science and partnerships with incubators to stay ahead of beauty trends, enhance the customer experience and maintain brand strength in highly competitive, even mature markets.

The company’s innovation-driven dominance owes much to a formidable platform built over generations. Straddling every beauty category, price point, and geography, its huge scale is an asset. L’Oréal’s advertising and R&D budget gives it a share of voice 1.5 times its market share3 – a loudspeaker unmatched by rivals. Meanwhile, a decentralised structure, backed up by a world class supply chain and digital infrastructure, lets it move with the agility of a start-up and the muscle of a multinational. That combination has allowed L’Oréal consistently to outpace the global beauty market’s already respectable 4-5 percent annual growth.4

In consumer healthcare, global leader Haleon spends over 21% of its revenue on R&D and marketing, deploying clinical research for product differentiation.5 Notably, studies conducted in collaboration with Harvard Medical School demonstrate that Centrum Silver – a combination of vitamins and selected minerals used to prevent or treat vitamin deficiency – actually enhances memory performance, while toothpaste Sensodyne Clinical White is scientifically proven to whiten teeth by two shades without enamel damage – setting it apart in a competitive marketplace.

Finally, in the beverages sector, Coca-Cola, which operates over 500 brands across soft drinks, waters, juices, teas and coffees, continues to expand its functional portfolio through strategic innovation. This year's launch of Simply Pop, Coke’s first prebiotic soft drink, reflects an evolving consumer preference for gut health products. Meanwhile, the Fairlife brand has emerged as a leader in the U.S. protein drink segment, employing patented ultra-filtration technology to enhance protein and calcium content while reducing lactose and sugar.

Despite currency headwinds and macro-economic turbulence, Coca-Cola has continued to grow its earnings in U.S. dollar terms, a testament to the strength and alignment of its global system. Central to this resilience is the company's “Total Beverage Company” strategy, which prioritises value over volume, expanding its portfolio beyond traditional carbonated soft drinks. Coca-Cola’s strategic refranchising of bottling operations has streamlined its structure, reduced capital intensity and directed focus to higher return activities. This has resulted in improved gross and operating margins, as well as higher returns on capital, supporting a more favourable valuation multiple. In our view, Coca-Cola’s integrated growth strategy, underpinned by innovation and operational efficiency, positions it well to navigate economic challenges and sustain its market leadership.

In order to thrive, even the world’s most enduring franchises have to keep evolving. We continue to deepen our understanding of companies that demonstrate innovation to underpin longevity, and plan to bring you further examples across other sectors we own. Whether through groundbreaking product development or cutting-edge AI applications, in our view high quality companies that prioritise sustained innovation remain best positioned to navigate market shifts, capture new opportunities, and drive long-term success.


1 Source: Procter & Gamble annual report 2024
2 Source: L’Oréal annual report 2024
3 Source: Morgan Stanley Research
4 Source: L’Oréal annual report 2024
5 Source: Haleon annual report 2024

International Equity Team

The International Equity team follows a disciplined investment process based on fundamental analysis and bottom-up stock selection. They believe that the best route to attractive long-term returns is through compounding and providing reduced downside participation.

The Author

IMPORTANT INFORMATION

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market.

A separately managed account may not be appropriate for all investors. Separate accounts managed according to the particular Strategy may include securities that may not necessarily track the performance of a particular index. A minimum asset level is required.

For important information about the investment managers, please refer to Form ADV Part 2.

The views and opinions and/or analysis expressed are those of the author or the investment team as of the date of preparation of this material and are subject to change at any time without notice due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all investment personnel at Morgan Stanley Investment Management (MSIM) and its subsidiaries and affiliates (collectively “the Firm”), and may not be reflected in all the strategies and products that the Firm offers.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors or the investment team. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific strategy or product the Firm offers. Future results may differ significantly depending on factors such as changes in securities or financial markets or general economic conditions.

This material has been prepared on the basis of publicly available information, internally developed data and other third-party sources believed to be reliable. However, no assurances are provided regarding the reliability of such information and the Firm has not sought to independently verify information taken from public and third-party sources.

This material is a general communication, which is not impartial and all information provided has been prepared solely for informational and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

Charts and graphs provided herein are for illustrative purposes only. Past performance is no guarantee of future results.

The indexes are unmanaged and do not include any expenses, fees or sales charges. It is not possible to invest directly in an index. Any index referred to herein is the intellectual property (including registered trademarks) of the applicable licensor. Any product based on an index is in no way sponsored, endorsed, sold or promoted by the applicable licensor and it shall not have any liability with respect thereto.

This material is not a product of Morgan Stanley’s Research Department and should not be regarded as a research material or a recommendation.

The Firm has not authorised financial intermediaries to use and to distribute this material, unless such use and distribution is made in accordance with applicable law and regulation. Additionally, financial intermediaries are required to satisfy themselves that the information in this material is appropriate for any person to whom they provide this material in view of that person’s circumstances and purpose. The Firm shall not be liable for, and accepts no liability for, the use or misuse of this material by any such financial intermediary.

This material may be translated into other languages. Where such a translation is made this English version remains definitive. If there are any discrepancies between the English version and any version of this material in another language, the English version shall prevail.

The whole or any part of this material may not be directly or indirectly reproduced, copied, modified, used to create a derivative work, performed, displayed, published, posted, licensed, framed, distributed or transmitted or any of its contents disclosed to third parties without the Firm’s express written consent. This material may not be linked to unless such hyperlink is for personal and non-commercial use. All information contained herein is proprietary and is protected under copyright and other applicable law.

Morgan Stanley Investment Management is the asset management division of Morgan Stanley.

DISTRIBUTION

This material is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

MSIM, the asset management division of Morgan Stanley (NYSE: MS), and its affiliates have arrangements in place to market each other’s products and services.  Each MSIM affiliate is regulated as appropriate in the jurisdiction it operates. MSIM’s affiliates are: Eaton Vance Management (International) Limited, Eaton Vance Advisers International Ltd, Calvert Research and Management, Eaton Vance Management, Parametric Portfolio Associates LLC, and Atlanta Capital Management LLC.

This material has been issued by any one or more of the following entities:

EMEA

This material is for Professional Clients/Accredited Investors only.

In the EU, MSIM and Eaton Vance materials are issued by MSIM Fund Management (Ireland) Limited (“FMIL”). FMIL is regulated by the Central Bank of Ireland and is incorporated in Ireland as a private company limited by shares with company registration number 616661 and has its registered address at 24-26 City Quay, Dublin 2, DO2 NY19, Ireland.

Outside the EU, MSIM materials are issued by Morgan Stanley Investment Management Limited (MSIM Ltd) is authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA.

In Switzerland, MSIM materials are issued by Morgan Stanley & Co. International plc, London (Zurich Branch) Authorised and regulated by the Eidgenössische Finanzmarktaufsicht ("FINMA"). Registered Office: Beethovenstrasse 33, 8002 Zurich, Switzerland.

Outside the US and EU, Eaton Vance materials are issued by Eaton Vance Management (International) Limited (“EVMI”) 125 Old Broad Street, London, EC2N 1AR, UK, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority.

Italy: MSIM FMIL (Milan Branch), (Sede Secondaria di Milano) Palazzo Serbelloni Corso Venezia, 16 20121 Milano, Italy. The Netherlands: MSIM FMIL (Amsterdam Branch), Rembrandt Tower, 11th Floor Amstelplein 1 1096HA, Netherlands. France: MSIM FMIL (Paris Branch), 61 rue de Monceau 75008 Paris, France. Spain: MSIM FMIL (Madrid Branch), Calle Serrano 55, 28006, Madrid, Spain. Germany: MSIM FMIL Frankfurt Branch, Große Gallusstraße 18, 60312 Frankfurt am Main, Germany (Gattung: Zweigniederlassung (FDI) gem. § 53b KWG). Denmark: MSIM FMIL (Copenhagen Branch), Gorrissen Federspiel, Axel Towers, Axeltorv2, 1609 Copenhagen V, Denmark.

MIDDLE EAST

Dubai: MSIM Ltd (Representative Office, Unit Precinct 3-7th Floor-Unit 701 and 702, Level 7, Gate Precinct Building 3, Dubai International Financial Centre, Dubai, 506501, United Arab Emirates. Telephone: +97 (0)14 709 7158).

This document is distributed in the Dubai International Financial Centre by Morgan Stanley Investment Management Limited (Representative Office), an entity regulated by the Dubai Financial Services Authority (“DFSA”). It is intended for use by professional clients and market counterparties only. This document is not intended for distribution to retail clients, and retail clients should not act upon the information contained in this document.

This document relates to a financial product which is not subject to any form of regulation or approval by the DFSA. The DFSA has no responsibility for reviewing or verifying any documents in connection with this financial product. Accordingly, the DFSA has not approved this document or any other associated documents nor taken any steps to verify the information set out in this document, and has no responsibility for it. The financial product to which this document relates may be illiquid and/or subject to restrictions on its resale or transfer. Prospective purchasers should conduct their own due diligence on the financial product. If you do not understand the contents of this document, you should consult an authorised financial adviser.

U.S.

NOT FDIC INSURED | OFFER NO BANK GUARANTEE | MAY LOSE VALUE | NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY | NOT A DEPOSIT

Latin America (Brazil, Chile Colombia, Mexico, Peru, and Uruguay)

This material is for use with an institutional investor or a qualified investor only. All information contained herein is confidential and is for the exclusive use and review of the intended addressee, and may not be passed on to any third party. This material is provided for informational purposes only and does not constitute a public offering, solicitation or recommendation to buy or sell for any product, service, security and/or strategy. A decision to invest should only be made after reading the strategy documentation and conducting in-depth and independent due diligence.

ASIA PACIFIC

Hong Kong: This material is disseminated by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this material have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this material shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong. Singapore: This material is disseminated by Morgan Stanley Investment Management Company and should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore (“SFA”); (ii) to a “relevant person” (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. This publication has not been reviewed by the Monetary Authority of Singapore.   Australia: This material is provided by Morgan Stanley Investment Management (Australia) Pty Ltd ABN 22122040037, AFSL No. 314182 and its affiliates and does not constitute an offer of interests. Morgan Stanley Investment Management (Australia) Pty Limited arranges for MSIM affiliates to provide financial services to Australian wholesale clients. Interests will only be offered in circumstances under which no disclosure is required under the Corporations Act 2001 (Cth) (the “Corporations Act”). Any offer of interests will not purport to be an offer of interests in circumstances under which disclosure is required under the Corporations Act and will only be made to persons who qualify as a “wholesale client” (as defined in the Corporations Act). This material will not be lodged with the Australian Securities and Investments Commission.

Japan

For professional investors, this material is circulated or distributed for informational purposes only. For those who are not professional investors, this material is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)’s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”).  This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions.  All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.20% per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This material is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: the Japan Securities Dealers Association, The Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.